NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘SR One’

19 June 2014

Polaris backs biopharmaceutical startup Navitor’s $23.5m Series A

navitor Biopharmaceutical company Navitor Pharmaceuticals has raised a $23.5m Series A round from venture capital backer.

9 April 2014

Mystery investor joins venture backers in $41m Alios BioPharma Series B

virus2_sq A string of venture capital firms have renewed their backing of biotech business Alios BioPharma to help it develop treatments for respiratory viral diseases.

18 November 2013

Imperial Innovations heads up £20m investment in biotech developer Mission Therapeutics

UK technology commercialisation and investment firm Imperial Innovations has committed £4.5m of a £20m funding round for biotechnology company Mission Therapeutics alongside corporate venture investor Pfizer Venture Investments and existing investors Sofinnova Partners, SR One and Roche Venture Fund.

1 August 2013

RA Capital backs mammoth $60m Series C round for RNA Interference

dna RA Capital has helped emerging pharmaceutical company RNA Interference close an enormous $60m Series C financing round.

10 December 2012

Astellas joins existing venture investors in £3.75m Bicycle Therapeutics deal

bicycle_sq Astellas Venture Management, the venture arm of Astellas Pharma, has backed a £3.75m financing round for UK business Bicycle Therapeutics.

26 October 2012

GlaxoSmithKline VC arm leads $35m Thrasos Therapeutics round

Thrasos Therapeutics kidney - AltAssets Private Equity News The corporate venture arm of pharmaceutical giant GlaxoSmithKline has led a $35m financing round for kidney injury treatment company Thrasos Therapeutics.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014